FIELD: medicine, neurology.
SUBSTANCE: it is necessary to detect neurological syndromes to evaluate them in points: coma - 9.61; spoor - 9.25; somnolence - 7.64, dyspnea up to 32/min - 7.96; dyspnea up to 32-40/min - 8.8; dyspnea above 40/min - 10.0; respiratory arrhythmia - 9.0; hyperthermia up to 38°C - 6.67; hyperthermia up to 38-39°C - 8.5; hyperthermia being above 39°C - 9.4; epileptiform syndrome - 8.0; psychoproductive syndromes - 5.03; affected critics - 4.02; meningeal coarse syndrome - 9.4; meningeal pronounced syndrome - 8.09; meningeal moderate syndrome - 6.71; right-hand pyramid syndrome 0-1 point - 8.05; right-hand pyramid syndrome 1.5-3.5 points - 4.83; right-hand pyramid syndrome 4-5 points - 1.0; left-hand pyramid syndrome (0-1) - 8.09; left-hand pyramid syndrome 1.5-3.5 points - 4.7; left-hand pyramid syndrome 4-5 points - 1.32; right-hand sensopyramid syndrome - 4.48; left-hand sensopyramid syndrome - 4.25; senso-motor coarse aphasia - 7.64; senso-motor pronounced aphasia - 4.93; senso-motor moderate aphasia - 3.04; motor coarse aphasia - 3.56; motor moderate and pronounced aphasia - 3.06; amnestic aphasia - 2.7; dearthria - 4.64; autotopagnosia - 6.3; hemionopsy - 2.5; pseudobulbar coarse syndrome - 9.5; pseudobulbar pronounced syndrome - 8.64; extrapyramid syndromes - 3.0; central and peripheral paresis of facial nerve - 4.63; pathological foot signs - 4.52; hemispheric paresis of glance - 7.2; stem paresis of glance - 7.0; vestibular coarse syndrome - 7.0; vestibular pronounced syndrome - 3.3; vestibular moderate syndrome - 3.3, atactic syndrome 4.58; Weber's coarse syndrome - 7.75, Weber's pronounced syndrome - 5.5; Weber's moderate syndrome - 4.0; red-nuclear syndrome - 5.5; Fovill's syndrome - 7.0; bifurcation syndrome - 7.0; Miyar-Gubler's syndrome - 3.0; Vallenberg-Zakharchenko's syndrome - 6.0; Avellis' syndrome - 6.0; bulbar coarse syndrome - 8.5; bulbar pronounced syndrome - 5.8; bulbar moderate syndrome - 4.4. Then one should determine clinical coefficient of ischemic insult © as the ratio of points' sum of general cerebral syndromocomplex gainst that of focal one and the value of possible lethality (Y) in percentage should be calculated by the following formula: Y=25C+15.83. The innovation provides original estimation of neurological syndromes.
EFFECT: higher significance of prediction.
1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE CASES OF ISCHEMIC INSULT | 1997 |
|
RU2124365C1 |
METHOD FOR PREDICTING THE OUTCOME OF AN ACUTE PERIOD OF ISCHEMIC STROKE IN PATIENTS NOT SUFFERING TYPE 2 DIABETES MELLITUS | 2019 |
|
RU2731177C1 |
METHOD FOR PREDICTION OF NEUROLOGICAL RECOVERY IN PATIENTS IN ACUTE ISCHEMIC STROKE | 2010 |
|
RU2437099C1 |
METHOD FOR PREDICTING THE COURSE OF AN ACUTE PERIOD OF ISCHEMIC STROKE IN TYPE 2 DIABETES MELLITUS PATIENTS | 2019 |
|
RU2739118C1 |
METHOD FOR DETECTING INDICATIONS FOR TREATING ISCHEMIC INSULT DURING RESTORATIVE PERIOD WITH NEUROMYDIN PREPARATION | 2005 |
|
RU2281690C1 |
METHOD FOR PREDICTION OF PROBABILITY OF FATAL OUTCOME OF ISCHEMIC STROKE IN PATIENTS WITHOUT DEPRESSION OF CONSCIOUSNESS | 2011 |
|
RU2466396C1 |
METHOD FOR PREDICTION OF CLINICAL OUTCOME OF NON-TRAUMATIC INTRACRANEAL HAEMORRHAGES | 2014 |
|
RU2566612C1 |
METHOD FOR PREDICTING DYSCIRCULATORY ENCEPHALOPATHY DECOMPENSATION CHANCE AFTER CEREBRAL STROKE | 2004 |
|
RU2292845C2 |
METHOD FOR PREDICTING OUTCOME OF ACUTE PERIOD OF ISCHEMIC STROKE ASSOCIATED WITH COVID-19 | 2021 |
|
RU2763834C1 |
METHOD FOR TREATING STROKE CASES | 2004 |
|
RU2283121C2 |
Authors
Dates
2007-04-27—Published
2005-03-04—Filed